earnings
confidence high
sentiment neutral
materiality 0.50
Iradimed Q2 revenue flat at $20.5M, EPS down 9% to $0.41; reaffirms FY guidance
IRADIMED CORP
2026-Q2 EPS
reported $0.86
vs consensus $0.43
▲ beat
(+100.7%)
- Q2 revenue $20.5M, up 0.5% YoY; GAAP EPS $0.41, down 9%; non-GAAP EPS $0.46, down 7%.
- Net income $5.2M, down 10% YoY; gross margin 74% vs 78% prior year.
- Declares $0.20/share quarterly dividend, payable Aug 28, 2026, record Aug 14, 2026.
- Reaffirms FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP $2.09-2.24.
- New 3870 MR IV pump launch underway; >70% of new pump orders for quad stack configuration.